These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2080240)

  • 1. The occurrence of carbohydrate antigens (CA 19-9, CA-50) in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Acta Histochem Suppl; 1990; 38():183-7. PubMed ID: 2080240
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Makovitzky J; Schwenk J
    Acta Histochem Suppl; 1990; 40():143-6. PubMed ID: 2091042
    [No Abstract]   [Full Text] [Related]  

  • 3. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
    Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lex and Ley antigen expression in human pancreatic cancer.
    Kim YS; Itzkowitz SH; Yuan M; Chung Y; Satake K; Umeyama K; Hakomori S
    Cancer Res; 1988 Jan; 48(2):475-82. PubMed ID: 3335015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):465-76. PubMed ID: 2499104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of the carbohydrate antigen CA-50 in pancreatic disease.
    Blind PJ; Dahlgren ST
    Acta Chir Scand; 1987 Jan; 153(1):45-9. PubMed ID: 3472420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Pancreatic polypeptide" A cells. Demonstration in the adult human pancreas and role in pancreatic pathology].
    Berger G; Guillaud MM; Patricot LM; Beau G; Toccanier MF
    Arch Anat Cytol Pathol; 1978; 26(3-4):153-7. PubMed ID: 373648
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
    Safi F; Roscher R; Beger HG
    Hepatogastroenterology; 1989 Dec; 36(6):419-23. PubMed ID: 2613165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic carcinoma developing in chronic pancreatitis: a report of four cases.
    Haas O; Guillard G; Rat P; Friedman S; Favre JP
    Hepatogastroenterology; 1990 Jun; 37(3):350-1. PubMed ID: 2373470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pancreatic carcinoma in chronic pancreatitis with inflammatory tumor of the head of the pancreas].
    Schlosser W; Schoenberg MH; Rhein E; Siech M; Gansauge F; Beger HG
    Z Gastroenterol; 1996 Jan; 34(1):3-8. PubMed ID: 8776168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
    Safi F; Roscher R; Beger HG
    Bull Cancer; 1990; 77(1):83-91. PubMed ID: 2180502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
    Schwenk J; Makovitzky J
    Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
    Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
    Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood CA 19-9 in the diagnosis of carcinoma of the pancreas: a critical approach].
    Angonese C; Basso D; Del Favero G; Fabris C; Tremolada C; Plebani M; Burlina A; Naccarato R
    Ann Ital Med Int; 1987; 2(2):138-42. PubMed ID: 3275279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunology of acute and chronic pancreatitis].
    Pour PM; Takasaki H; Büchler M
    Verh Dtsch Ges Pathol; 1987; 71():255-65. PubMed ID: 3481506
    [No Abstract]   [Full Text] [Related]  

  • 18. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
    Ozkan H; Kaya M; Cengiz A
    Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.